Court reverses $482 million case against JNJ's Cordis
WASHINGTON (Reuters) - Cordis Corp, a Johnson and Johnson (JNJ.N) subsidiary, did not infringe upon a stent patent owned by a radiologist, an appeals court said on Thursday, reversing a ruling by a lower court which had ordered Cordis to pay $482 million.
The U.S. Court of Appeals for the Federal Circuit reversed a ruling from a Texas jury, which had found Cordis guilty of infringement and ordered the payment, plus interest.
The appeals court ruled that Cordis had not infringed.
A lawyer for the radiologist, Bruce Saffran, was not immediately available.
The case in the U.S. District Court for the Eastern District of Texas was No. 07-CV-0451. The case at the U.S. Court of Appeals for the Federal Circuit is Bruce Saffran v. Johnson & Johnson and Cordis Corp., No. 2012-1043.
(Reporting by Diane Bartz; Editing by Gerald E. McCormick)
- Islamic State executes soldiers, takes hostages at Syria base: social media
- WHO shuts Sierra Leone lab after worker infected with Ebola
- Gaza truce holding but Israel's Netanyahu under fire at home |
- Talks optimism fades as Ukraine says Russia makes new incursion |
- 'Men in green' raise suspicions of east Ukrainian villagers